Safety considerations: breastfeeding after transplant
- PMID: 23782661
- DOI: 10.7182/pit2013803
Safety considerations: breastfeeding after transplant
Abstract
Organ transplant is an effective treatment for end-stage organ failure. For women, restoration of organ function can restore fertility and the ability to successfully carry a pregnancy. Posttransplant pregnancies have been reported among recipients of all types of solid organ transplants via case and center reports plus registry data. Stable graft function is dependent on prevention of rejection, currently accomplished by using maintenance immunosuppressant medications, to which the fetus is exposed in utero. Common among neonatal outcomes in transplant recipients are preterm and low-birth-weight infants. Emotional, nutritional, and immunologic benefits of breastfeeding have been well-documented and could be valuable for these newborns. Concern must be directed at the effects of the child's exposure to immunosuppressive agents excreted into the breast milk. Breastfeeding could be considered in transplant recipients if it can be shown that the level of exposure does not result in risks to the newborn, immediately and throughout childhood. Despite concerns of health care professionals, some recipients have chosen to breastfeed. Breastfeeding after transplant must be approached with consideration of many issues, and the potential risks require further study. This review focuses on benefits of breastfeeding, common immunosuppressive agents used in organ transplant recipients, a summary of the reports of women who have breastfed their infants while on immunosuppressive therapy and the published studies on breastfeeding and immunosuppressive agents. Recommendations are provided to guide health care professionals to help mothers receiving immunosuppressive agents to make informed choices about breastfeeding their infants.
Similar articles
-
Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.Clin Transpl. 2006:57-70. Clin Transpl. 2006. PMID: 18368705
-
Immunosuppressant therapy in pregnant organ transplant recipients.Semin Perinatol. 2007 Dec;31(6):363-71. doi: 10.1053/j.semperi.2007.09.006. Semin Perinatol. 2007. PMID: 18063120 Review.
-
Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.Clin Transpl. 2002:121-30. Clin Transpl. 2002. PMID: 12971441
-
Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.Clin Transpl. 2000:123-34. Clin Transpl. 2000. PMID: 11512306
-
Role of breast-feeding in the prevention and treatment of diarrhoea.J Diarrhoeal Dis Res. 1990 Sep;8(3):68-81. J Diarrhoeal Dis Res. 1990. PMID: 2243179 Review.
Cited by
-
Outcomes of Children with Fetal and Lactation Immunosuppression Exposure Born to Female Transplant Recipients.Paediatr Drugs. 2022 Sep;24(5):483-497. doi: 10.1007/s40272-022-00525-y. Epub 2022 Jul 23. Paediatr Drugs. 2022. PMID: 35870080 Review.
-
Breastfeeding and Medication Use in Kidney Disease.Adv Chronic Kidney Dis. 2020 Nov;27(6):516-524. doi: 10.1053/j.ackd.2020.05.007. Epub 2020 May 11. Adv Chronic Kidney Dis. 2020. PMID: 33328068 Free PMC article. Review.
-
Obstetrical and gynecologic challenges in the liver transplant patient.World J Transplant. 2020 Nov 28;10(11):320-329. doi: 10.5500/wjt.v10.i11.320. World J Transplant. 2020. PMID: 33312893 Free PMC article. Review.
-
Low Content of Cyclosporine A and Its Metabolites in the Colostrum of Post-Transplant Mothers.Nutrients. 2020 Sep 4;12(9):2713. doi: 10.3390/nu12092713. Nutrients. 2020. PMID: 32899873 Free PMC article.
-
Pharmacologic inhibition of mTORC1 mimics dietary protein restriction in a mouse model of lactation.J Anim Sci Biotechnol. 2020 Jun 29;11:67. doi: 10.1186/s40104-020-00470-1. eCollection 2020. J Anim Sci Biotechnol. 2020. PMID: 32612825 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical